Tower Research Capital LLC (TRC) - CANDEL THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CANDEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,955
-23.6%
8,647
+4.7%
0.00%
Q2 2023$10,410
+115566.7%
8,262
+25.6%
0.00%
Q1 2023$9
-30.8%
6,576
-8.8%
0.00%
-100.0%
Q4 2022$13
-99.9%
7,214
+74.4%
0.00%
Q3 2022$13,000
+225.0%
4,137
+239.4%
0.00%
Q2 2022$4,0001,219
+2157.4%
0.00%
Q1 2022$0540.00%
Other shareholders
CANDEL THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Northpond Ventures, LLC 1,935,215$3,464,0351.88%
Sands Capital Ventures, LLC 811,737$1,4530.40%
Empirical Asset Management, LLC 12,000$21,4800.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,700$237,5330.01%
Ergoteles LLC 26,114$46,7440.00%
FRANKLIN RESOURCES INC 1,125,000$2,013,7500.00%
Tower Research Capital LLC (TRC) 7,214$130.00%
WELLS FARGO & COMPANY/MN 98$1750.00%
NORTHERN TRUST CORP 14,483$25,9250.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CANDEL THERAPEUTICS INC shareholders